CDKN1A and colorectal carcinoma: In residual small cluster cells of the clinical CRC neoadjuvant therapy cases analyzed earlier, p21-negative states were observed in all cases, presumably because the patient tissues were collected at least 3 weeks after the final anticancer drug administration.